Infective Endocarditis Empirical therapy Antibiotic Guidelines. Contents
|
|
- Gregory Cannon
- 5 years ago
- Views:
Transcription
1 Infective Endocarditis Empirical therapy Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Group Additional author(s): as above Authors Division: Division of Clinical Support Services & Tertiary Medicine Unique ID: 144TD(C)25(C4) Issue number: 4 Expiry Date: November 2018 Contents Who should read this document?... 2 Key Practice Points... 2 Background/ Scope/ Definitions... 2 What is new in this version?... 3 Guideline... 3 Endocarditis, Infective Empirical treatment of Initial Investigations Diagnosis Treatment Native valve endocarditis indolent presentation Native valve endocarditis severe sepsis Native valve endocarditis severe sepsis AND risk factors Prosthetic valve endocarditis Therapeutic drug monitoring... 8 Standards... 8 Explanation of terms & Definitions... 8 References and Supporting Documents... 9 Roles and responsibilities... 9 Appendices... 9 Document Control Information... Error! Bookmark not defined. Policy Implementation Plan... Error! Bookmark not defined. Monitoring and Review... Error! Bookmark not defined. Endorsement... Error! Bookmark not defined. Screening Equality Analysis Outcomes... Error! Bookmark not defined. Page 1 of 9
2 Who should read this document? This policy applies to all clinical staff involved the prescribing of antimicrobials. Key Practice Points This policy highlights the roles and responsibilities of clinical staff involved in prescribing empirical antimicrobials for infective endocarditis. These guidelines are empiric. For organism specific advice and information about duration, refer to UK guidelines or discuss with microbiology. Background/ Scope/ Definitions Antimicrobial agents are among the most commonly prescribed drugs and account for 20% of the hospital pharmacy budget. Unfortunately, the benefits of antibiotics to individual patients are compromised by the development of bacterial drug resistance. Resistance is a natural and inevitable result of exposing bacteria to antimicrobials. Good antimicrobial prescribing will help to reduce the rate at which antibiotic resistance emerges and spreads. It will also minimise the many side effects associated with antibiotic prescribing, such as Clostridium difficile infection. It should be borne in mind that antibiotics are not needed for simple coughs and colds. In some clinical situations, where infection is one of several possibilities and the patient is not showing signs of systemic sepsis, a wait and see approach to antibiotic prescribing is often justified while relevant cultures are performed. This document provides treatment guidelines for the most common situations in which antibiotic treatment is required. The products and regimens listed here have been selected by the Trust's Medicines Management Group on the basis of published evidence. Doses assume a weight of 60-80kg with normal renal and hepatic function. Adjustments may be needed for the treatment of some patients. This document provides treatment guidelines for the appropriate use of antibiotics. The recommendations that follow are for empirical therapy and do not cover all clinical circumstances. Alternative antimicrobial therapy may be needed in up to 20% of cases. Alternative recommendations will be made by the microbiologist in consultation with the clinical team. This document refers to the treatment of adult patients (unless otherwise stated). Refer to up to date BNF/SPC for information on interactions, side effects, cautions and contraindications for individual drugs. In the case where an antibiotic prescription is necessary, probiotic therapy should be considered in order to reduce the risk of C. difficile infection Page 2 of 9
3 What is new in this version? Sectionn Native valve endocarditis severe sepsis (no risk factors for Gram-negatives*). The combination of vancomycin and gentamicin alone will not provide optimum Gram negative cover so if the source of infection remains unclear, broad spectrum cover with piperacillin/tazobactam or meropenem may be added to cover for sepsis of uncertain origin. Guideline Endocarditis, Infective Empirical treatment of These guidelines are for empiric therapy only, if the causative organism is identified, a microbiologist MUST be contacted for treatment advice. For advice on duration, refer to UK guidelines Gould et al (see references section for document details). 1. Initial Investigations A high index of suspicion and a low threshold for investigation are essential to exclude infective endocarditis in high risk patients. The British Society for Antimicrobial Chemotherapy recommends that echocardiography must be performed as soon as possible in all patients with suspected infective endocarditis, ideally within 24 hours. Transthoracic echocardiography (TTE) is the initial investigation of choice (sensitivity 70-80%). Blood cultures should be taken BEFORE starting antibiotics in ALL cases. In patients with a subacute presentation, three blood culture sets should be taken from peripheral sites at least 6 hours apart. In patients with severe sepsis/septic shock, two blood culture sets should be taken within 1 h prior to commencing empirical therapy. Blood cultures can be taken from the same site, but must be taken at different times. Empirical antibiotic treatment should be started before the results of blood cultures are known. Once the results of the blood cultures and antibiotic sensitivities are known, adjust the prescribed therapy and duration according to advice from microbiology. Repeat blood cultures are not recommended. Culture Negative Endocarditis. In patients with blood culture negative infective endocarditis, first line serological testing for Coxiella (Q fever) and Bartonella should be performed. Page 3 of 9
4 In cases with an initial negative TTE/TOE, repeat TTE/TOE should be performed 7-10 days later if clinical suspicion remains high. Routine repeat echocardiography whilst on treatment is not required but repeat echocardiography may be required in some cases consult with cardiology in all cases of definite or probable endocarditis. ALL patients with a Staphylococcus aureus bacteraemia or a candidaemia should have a TTE, due to the frequency of IE in this setting, the virulence of these organisms, the devastating effects once intracardiac infection is established and/or the need for surgery. Patients should have a TTE within the first week of treatment (or within 24 hours if there is other evidence to suggest IE). Unexplained fevers in a paced patient should prompt a search for pacing lead associated endocarditis. All patients with suspected or confirmed endocarditis MUST be reviewed by a cardiologist and a microbiologist to ensure optimal treatment is achieved, in terms of antimicrobial choice, dose and duration. ALL therapy MUST be given by the IV route. Page 4 of 9
5 2. Diagnosis Duke criteria can be used to assist in the diagnosis of IE, but are not a substitute for clinical judgement. Table 1: Modified Duke criteria for diagnosis of infective endocarditis (adapted from Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy 2011). A diagnosis of definite infective endocarditis requires: two major criteria; or one major and three minor criteria; or five minor criteria. Criterion Diagnostic Type Major criteria Positive blood culture Evidence of endocardial involvement Minor criteria Predisposition to IE Fever Vascular phenomena Immunological phenomena Microbiology phenomena Echocardiographic findings Typical organism consistent with IE from TWO separate blood cultures drawn > 6 hours apart OR drawn within 1 hour in the presence of severe sepsis/septic shock. OR C.burnetii antiphase I IgG antibody titre >1:800. Positive echocardiogram for IE OR New valvular regurgitation (worsening or changing murmur is NOT sufficient). viridans streptococci, Streptococcus bovis or HACEK group, OR community-acquired Staphylococcus aureus or enterococci (in the absence of a primary focus). Predisposing heart condition or IVDU. Temperature >38.0 C Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial haemorrhage, conjunctival haemorrhages and Janeway lesions. Glomerulonephritis, Osler s nodes, Roth spots, Rheumatoid factor. Positive blood culture but does not meet a major criterion (as above). Serological evidence of active infection with an organism consistent with IE. Consistent with IE but do not met a major criterion (as above). Page 5 of 9
6 3. Treatment The empirical treatment advice is sub -divided into the following sections Section 3.1 Native valve endocarditis indolent presentation (i.e NOT acutely unwell) Section 3.2 Native valve endocarditis severe sepsis (no risk factors for Gram-negatives*) Section 3.3 Native valve endocarditis severe sepsis AND risk factors for Gram negatives* Section 3.4 Prosthetic valve endocarditis Section 3.5 Therapeutic drug monitoring for the empirical treatment management of infective endocarditis Doses quoted assume patients are of average weight with normal renal and hepatic function. If advice is required, contact the ward pharmacist or microbiologist. *Risk factors for Gram negative infection include: recurrent UTIs, biliary sepsis or intra-abdominal infection in the last 3 months 3.1 Native valve endocarditis indolent presentation (i.e NOT acutely unwell) Patients with a penicillin allergy see section 3.2 Amoxicillin 2g IV every 4 hours (if egfr<50ml/min discuss with microbiology) PLUS Gentamicin 1mg/kg (Ideal body weight) IV every 12 hours Adjust gentamicin dose appropriately if patient is elderly, has impaired renal function or is obese /underweight. This can be discussed with the ward pharmacist. For therapeutic drug monitoring of gentamicin, see section Native valve endocarditis severe sepsis (no risk factors for Gram-negatives*) Acutely unwell is defined as patient with embolic features, general sepsis syndrome and is haemodynamically unstable. Vancomycin IV PLUS Gentamicin 1mg/kg (Ideal body weight) IV every 12 hours Adjust vancomycin or gentamicin dose appropriately if patient is elderly, has impaired renal function or is obese /underweight. This can be discussed with the ward pharmacist. For therapeutic drug monitoring of gentamicin, see section 3.5. Page 6 of 9
7 This combination will not provide optimum Gram negative cover so if the source of infection remains unclear consider adding cover for sepsis of uncertain origin: Add Piperacillin/tazobactam 4.5g IV tds (bd if CrCl <20ml/min, CKD 5) Penicillin allergy without anaphylaxis/angioedema/bronchospasm: Add meropenem 1g every 8 hours Severe penicillin allergy/anaphylaxis/angioedema/bronchospasm Discuss with microbiology 3.3 Native valve endocarditis severe sepsis AND risk factors for Gram negatives* Vancomycin IV PLUS Meropenem 2g IV every 8 hours (if egfr<50ml/min discuss with microbiology) Patients with anaphylaxis, angiodema or bronchospasm to penicillins contact microbiology. Adjust vancomycin or gentamicin dose appropriately if patient is elderly, has impaired renal function or is obese /underweight. This can be discussed with the ward pharmacist. For therapeutic drug monitoring of vancomycin and gentamicin see section Prosthetic valve endocarditis Treat as per section 3.2 or 3.3 above depending on presence of risk factors for Gram negative infection, PLUS Rifampicin 600 mg twice daily orally/iv (use lower doses of rifampicin in severe renal impairment) Page 7 of 9
8 3.5 Therapeutic drug monitoring for the empirical treatment management of infective endocarditis Throughout therapy, antibiotic level monitoring must be conducted. The following table is a reference for appropriate blood levels: Antibiotic Sampling times Appropriate trough level Gentamicin Immediately 1mg/L before third dose and one hour after the end of administration Vancomycin Immediately 15-20mg/L before fourth dose or after 48hrs of therapy. Pre-dose (trough level required) Appropriate peak level 3-5mg/L n/a Standards Document the Indication/rationale for antimicrobial therapy, including clinical criteria relevant to this. Review and document the patient s allergy status Ensure the choice of antibiotic complies with the antibiotic guidelines and you have documented any clinical criteria relevant to the choice of agent. Document a management plan including a stop or review date. Where relevant, consider drainage of pus or surgical debridement/removal of foreign material. Explanation of terms & Definitions Not applicable Page 8 of 9
9 References and Supporting Documents Li J S, Sexton D, Mick N et al. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clinical Infect Dis 2000;30: Gould FK, Denning DW et al. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2011; 67: Habib G et al ESC Guidelines for the management of infective endocarditis. European Heart Journal August 2015 Roles and responsibilities All clinical staff involved in the prescribing of antimicrobials to adhere to this policy including full documentation on EPMAR as detailed. Appendices Not applicable Page 9 of 9
IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro
IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique
More informationChallenging clinical situation
Challenging clinical situation A young patient with prosthetic aortic valve endocarditis Gilbert Habib La Timone Hospital Marseille - France October 25 th 2014 Case report History of the disease Clinical
More informationDiagnostic strategy. Dr Pilar Tornos Hospital Vall d Hebron Barcelona
Diagnostic strategy Dr Pilar Tornos Hospital Vall d Hebron Barcelona Faculty disclosure Pilar Tornos I disclose the following financial relationships: Paid speaker for Recordati, Edwards. Diagnosis of
More informationDaniel C. DeSimone, MD Assistant Professor of Medicine
Daniel C. DeSimone, MD Assistant Professor of Medicine Faculty photo will be placed here Desimone.Daniel@mayo.edu 2015 MFMER 3543652-1 Infective Endocarditis Mayo School of Continuous Professional Development
More informationContents. 1. Introduction. J Antimicrob Chemother 2012; 67: doi: /jac/dkr450 Advance Access publication 14 November 2011
J Antimicrob Chemother 2012; 67: 269 289 doi:10.1093/jac/dkr450 Advance Access publication 14 November 2011 Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of
More informationNATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE
Welcome INFECTIVE ENDOCARDITIS: WHERE WE ARE AT 2005? DR MD HABIBUR RAHMAN FCPS(Medicine) NATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE DEFINITION OF INFECTIVE ENDOCARDITIS Infective endocarditis
More informationDr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences
Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences ١ ٢ ٣ A 57-year-old man presents with new-onset fever, shortness of breath, lower
More informationHeart on Fire: Infective Endocarditis. Objectives. Disclosure 8/27/2018. Mary McGreal DNP, RN, ANP-c, CCRN
Heart on Fire: Infective Endocarditis Mary McGreal DNP, RN, ANP-c, CCRN Objectives Discuss the incidence of infective endocarditis? Discuss the pathogenesis of infective endocarditis? Discuss clinical
More informationMichael Stander, Pharm.D.
Michael Stander, Pharm.D. Endocarditis: Goals Epidemiology Presentation of acute and subacute. Diagnosis: What is Dukes Criteria and how do we approach the diagnosis of endocarditis? Treatment: Understand
More informationBASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN
BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN When should I suspect infective endocarditis? Antibiotic regimen Patient care after completion of treatment Prophylactic Regimens Prosthetic Valve
More informationVEGETATION NEGATIVE INFECTIVE ENDOCARDITIS A VIEW POINT... Mumbai Dec 2005 Annual scientific sessions
VEGETATION NEGATIVE INFECTIVE ENDOCARDITIS A VIEW POINT... Mumbai Dec 2005 Annual scientific sessions S.Venkatesan,G.Gnanavelu,G.Karthikeyan,V.Jaganathan,R.Alagesan M.Annamalai,S.Shanmugasundaram, S.Geetha,A.Balaguru.G.Anuradha
More informationEndocarditis, including Prophylaxis
Endocarditis, including Prophylaxis ACOI Board Review 2018 gerald.blackburn@beaumont.org (No Disclosures) Infective Endocarditis Persistant bacteremia (blood cultures drawn >12 hrs apart) w/ organisms
More informationInfective Endocarditis
Definition Infective Endocarditis Pattaya Riengchan M.D. MAR 16, 2017 Infection of endocardial surface of the heart and implies the physical presence microorganisms in the lesion Heart valves are most
More informationUse ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:
Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic
More informationMicrobiological diagnosis of infective endocarditis; what is new?
Microbiological diagnosis of infective endocarditis; what is new? Dr Amani El Kholy, MD Professor of Clinical Pathology (Microbiology), Faculty of Medicine, Cairo University ESC 2017 1 Objectives Lab Diagnostic
More informationInfective Endocarditis
Infective Endocarditis Infective Endocarditis Historical Perspective.. A concretion larger than a pigeon s egg; contained in the left auricle. Burns, 1809 Osler s Gulstonian lectures provided the 1 st
More informationInfective endocarditis
Infective endocarditis This is caused by microbial infection of a heart valve (native or prosthetic), the lining of a cardiac chamber or blood vessel, or a congenital anomaly (e.g. septal defect). The
More informationFull title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control
Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes
More informationA Study of Infective Endocarditis in Malta
Science Journal of Clinical Medicine 2017; 6(6): 98-104 http://www.sciencepublishinggroup.com/j/sjcm doi: 10.11648/j.sjcm.20170606.11 ISSN: 2327-2724 (Print); ISSN: 2327-2732 (Online) A Study of Infective
More informationEchocardiography after stroke - where to look
Echocardiography after stroke - where to look Vuyisile T. Nkomo, MD,MPH, FACC, FASE Joint Cardiac Imaging Society of South Africa/Mayo Clinic Echocardiography Workshop 2017 2016 MFMER slide-1 Disclosures
More informationInfective Endocarditis
Infective Endocarditis Definition Historical perspective Classification Epidemiological Features Etiology Pathogenesis Clinical presentation Diagnosis Treatment options Prevention Infective endocarditis
More informationOverview. Clinical Scenario. Endocarditis: Treatment & Prevention. Prophylaxis The Concept. Jeremy D. Young, MD, MPH. Division of Infectious Diseases
Endocarditis: Treatment & Prevention Jeremy D. Young, MD, MPH Division of Infectious Diseases Clinical Scenario Patient with MVP scheduled to have wisdom teeth extracted. Has systolic murmur with mid-systolic
More informationINFECTIOUS endocarditis (IE) is a
ORIGINAL INVESTIGATION Diagnosis of Infective Endocarditis Sensitivity of the Duke vs von Reyn Criteria Maija Heiro, MD; Jukka Nikoskelainen, MD, PhD; Jaakko J. Hartiala, MD, PhD; Markku K. Saraste, MD;
More informationInfective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD
Infective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD Infective endocarditis (IE) is an inflammation of the endocardium.. inner of the heart muscle & the epithelial lining of heart valves.
More informationTrust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults
A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job
More informationAn assessment of the current diagnostic criteria for infective endocarditis
REVIEW An assessment of the current diagnostic criteria for infective endocarditis Albert W Chan MD FRCPC, Heather J Ross MD FRCPC AW Chan, HJ Ross. An assessment of the current diagnostic criteria for
More informationCARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS
CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS This Care Pathway has been developed by a multidisciplinary team. It
More informationGeneral management of infective endocarditis
General management of infective endocarditis Team approach in infective endocarditis Gilbert Habib La Timone Hospital Marseille - France Eurovalves Barcelona 2017 The echolab «Heart Team" Infective Endocarditis
More informationMANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION
MANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION RRCV CMG Renal and Transplant Service 1. Introduction Catheter related blood stream infection (CR-BSI) is a common complication in patients
More informationThe changing landscape of infective endocarditis (IE)in congenital heart disease (CHD)
The changing landscape of infective endocarditis (IE)in congenital heart disease (CHD) Rekwan Sittiwangkul,MD Department of Pediatrics. Chiang Mai University Hospital, 24 th March 2018 Infective endocarditis
More informationThe microbial diagnosis of infective endocarditis (IE)
The microbial diagnosis of infective endocarditis (IE) Pierrette Melin Medical Microbiology pm-chulg sbimc 10.05.2007 1 Introduction for diagnosis Review of microbiological investigation of IE and perspectives
More informationBacterial Endocarditis
Objectives Bacterial Endocarditis John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota Identify which valves are commonly involved with endocarditis Identify common pathogens
More informationTrust Guideline for the Management of: Condition or Procedure in Adults and / or Children
Trust Guideline for the Management of: Condition or Procedure in Adults and / or Children A clinical guideline recommended For use in: By: For: Division responsible for document: Key words: Name of document
More informationInfected cardiac-implantable electronic devices: diagnosis, and treatment
Infected cardiac-implantable electronic devices: diagnosis, and treatment The incidence of infection following implantation of cardiac implantable electronic devices (CIEDs) is increasing at a faster rate
More informationRenal Unit. Catheter Related Bacteraemia Guidelines
Renal Unit Policy Manager Drew Henderson Policy Group Renal Unit Policy Established 21/01/2014 Policy Review Period/Expiry 21/01/2015 Last Updated 21/01/2014 This policy does apply to Medical/Dental Staff
More informationInfective Endocarditis
Frank Lowy Infective Endocarditis 1. Introduction Infective endocarditis (IE) is an infection of the heart valves. A large number of different bacteria are capable of causing this disease. Depending on
More informationAn approach to a patient with infective endocarditis
An approach to a patient with infective endocarditis J Hitzeroth, 1 MB ChB, DA (SA), FCP (SA), Cert Cardiology (SA); N Beckett, 2 MB ChB, PG Dip FM (SA); P Ntuli, 3 MB ChB, FCP (SA), Cert Cardiology (SA)
More informationAntimicrobial Management of Febrile Neutropenic Sepsis
Antimicrobial Management of Febrile Neutropenic Sepsis Written by: Dr J Joseph, Consultant Haematologist Dr K Gajee, Consultant Microbiologist Amended by: Larissa Claybourn, Antimicrobial Pharmacist Date:
More informationInfections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)
3 Infections Amenable to OPAT (Nabin Shrestha + Ajay Mathur) Decisions regarding outpatient treatment of infections vary with the institution, the prescribing physician, the individual patient s condition
More informationEndocardite infectieuse
Endocardite infectieuse 1. Raccourcir le traitement: jusqu où? 2. Proposer un traitement ambulatoire: à partir de quand? Endocardite infectieuse A B 90 P = 0.014 20 P = 0.0005 % infective endocarditis
More informationPr AMEL OMEZZINE LETAIEF CHU FarhatHached Sousse
Pr AMEL OMEZZINE LETAIEF CHU FarhatHached Sousse cours de collège infectiologie Sousse le27/02/2013 ENDOCARDITIS There is a change in epidemiology Clinical features of IE remains classical Diagnosis of
More informationInfective endocarditis (IE) is an
Jason Andrade, MD, Ellamae Stadnick, MD, Aneez Mohamed, MD Infective endocarditis prophylaxis: An update for clinical practice Antibiotic therapy to prevent endocarditis is now considered un - necessary
More informationDisclosures. Native Valve Endocarditis and its Complications. Outline. Outline. Basics. Basics 3/23/2017
Native Valve Endocarditis and its Complications SCVP and Binford Dammin Society of Infectious Disease Pathologists Shared Companion Meeting USCAP 2017 Annual Meeting Disclosures Relevant financial relationships
More informationInfective Endocarditis
Chapter 32 Infective Endocarditis Lisa B. Hightow and Meera Kelley The term infective endocarditis (IE) refers to infection of the endocardial surface of the heart and implies a physical presence of microganisms
More informationINTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS
Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title
More informationJoshua Budhu M.S, Dorian Wood B.S, Marvin Crawford M.D, Khuram Ashraf M.D, Frederick Doamekpor M.D, Olufunke Akinbobuyi M.D
Accepted Manuscript Aerococcus Viridans Infectious Endocarditis Complicated by Splenic Infarction Joshua Budhu M.S, Dorian Wood B.S, Marvin Crawford M.D, Khuram Ashraf M.D, Frederick Doamekpor M.D, Olufunke
More informationEchocardiography in Endocarditis
Echocardiography in Endocarditis Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Demographics of IE Incidence is 1.4 12.7/100,000
More informationManagement of infective endocarditis in children
Management of infective endocarditis in children Ashutosh Marwah, MD* Savitri Shrivastava, MD DM FAMS FACC* INTRODUCTION Infective endocarditis (IE) continues to remain a serious disease despite advances
More informationApport des recommandations européennes
Apport des recommandations européennes Gilbert Habib Cardiology Department- La Timone Marseille - France Bordeaux le 28 Juin 2011 Infective Endocarditis: a changing disease new high-risk subgroups IVDA
More informationECHOCARDIOGRAPHY. Patient Care. Goals and Objectives PF EF MF LF Aspirational
Patient Care Be able to: Perform and interpret basic TTE and X cardiac Doppler examinations Perform and interpret a comprehensive X TTE and cardiac Doppler examination Perform and interpret a comprehensive
More informationA CASE OF RIGHT SIDED INFECTIVE ENDOCARDITIS WITH REACTIVE KNEE ARTHRITIS AND ACUTE KIDNEY INJURY Suresh Babu S 1, A. K. Badrinath 2, K.
A CASE OF RIGHT SIDED INFECTIVE ENDOCARDITIS WITH REACTIVE KNEE ARTHRITIS AND ACUTE KIDNEY INJURY Suresh Babu S 1, A. K. Badrinath 2, K. Suresh 3 HOW TO CITE THIS ARTICLE: Suresh Babu S, A. K. Badrinath,
More informationAdult Institutional Pharmacokinetics Protocol
Adult Institutional Pharmacokinetics Protocol Policy Title: Clinical Pharmacokinetics (PK) Service Policy Policy Statement: It is the policy of UMHC that PK consult orders (for vancomycin or aminoglycosides)
More informationApril 16, 09:00-09:15 중앙대학교 윤신원
April 16, 09:00-09:15 중앙대학교 윤신원 When to perform Echocardiography in IE? Vegetations?(pathologic Whatever the level hallmark) of suspicion Intracardiac abscess? Confirm or R/O at the Earliest opportunity.
More informationClinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)
VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin
More informationSepsis and Infective Endocarditis
Sepsis and Infective Endocarditis Michal Holub Department of Infectious Diseases First Faculty of Medicine Charles University in Prague and University Military Hospital Bacteremia and Sepsis bacteremia
More informationGuidelines for The Management of Infective Endocarditis
Guidelines for The Management of Infective Endocarditis By Dr. Sinan Butrus F.I.C.M.S Clinical Standards & Guidelines Kurdistan Board For Medical Specialties Infective endocarditis IE is an infection of
More informationDiagnosis and Treatment of Bacterial Endocarditis
Infectious diseases Board Review Manual Statement of Editorial Purpose The Hospital Physician Infectious Diseases Board Review Manual is a study guide for fellows and practicing physicians preparing for
More informationIE with cerebral hemorrhage
IE with cerebral hemorrhage Gilbert Habib / Patrizio Lancellotti La Timone Hospital Marseille - France Palermo, 26 April 2018 Case report: aortic bioprosthetic IE History of the disease 75 year-old man
More informationAntimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections
Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections Version 7.2 PAGL Inclusion Approved at January 2017 PGC APPROVED BY: TRUST REFERENCE: B3/2017 AWP REF: UHL Policies and
More informationBSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin
BSWH Pharmacist Continuing Education 2015 PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin Objectives Define basic pharmacodynamic and pharmacokinetic principles Describe
More informationUpdate on the prevention, diagnosis and management of Infective Endocarditis (IE)
Update on the prevention, diagnosis and management of Infective Endocarditis (IE) Dr.Ahmed Yahya Mohammed Alarhabi MD, MsC,FcUSM,FACC,MAHA Consultant Interventional Cardiologist Head of Cardiac Center
More informationNew guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. D. C. Shanson
Journal of Antimicrobial Chemotherapy (1998) 42, 292 296 New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis JAC D. C. Shanson Microbiology Department,
More informationThe Challenge of Managing Staphylococcus aureus Bacteremia
The Challenge of Managing Staphylococcus aureus Bacteremia M A R G A R E T G R A Y B S P F C S H P C L I N I C A L P R A C T I C E M A N A G E R N O R T H / I D P H A R M A C I S T A L B E R T A H E A
More informationA study of clinical and etiological profile of infective endocarditis and its correlation with echocardiography in patients of rheumatic heart disease
International Journal of Advances in Medicine Sarkar A et al. Int J Adv Med. 2017 Oct;4(5):1323-1327 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20174177
More informationLatest on Catheter interventions on the pulmonary valve and Infective Endocarditis
Latest on Catheter interventions on the pulmonary valve and Infective Endocarditis Andreas Eicken Deutsches Herzzentrum München, Klinik für Kinderkardiologie und angeborene Herzfehler, Technische Universität
More informationPOCKET GUIDELINES FOR HEALTHCARE PROVIDERS
1 ST EDITION CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION, DIAGNOSIS AND MANAGEMENT OF INFECTIVE ENDOCARDITIS POCKET GUIDELINES FOR HEALTHCARE PROVIDERS 1 ST EDITION CLINICAL PRACTICE GUIDELINES FOR
More informationJoint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics
A clinical guideline recommended For use in: All clinical areas where vancomycin is prescribed for Children aged 1 month to 16 years By: All medical, nursing, pharmacy, microbiology and phlebotomy paediatric
More informationClinical Indications for Echocardiography
Clinical Indications for Echocardiography Echocardiography is widely utilised and potential applications are increasing with advances in technology. The aim of this document is two-fold: 1) To define clinical
More informationInitiating Aminoglycosides Safely. Last updated: July 2016, Version 5 Questions/Comments?
Initiating Aminoglycosides Safely Last updated: July 2016, Version 5 Questions/Comments? Email Mark.McIntyre@uhn.ca Click orange buttons to navigate protocol. Index: Aminoglycoside Dosing Algorithms Objective
More informationPOLICY FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS
POLICY F TREATMENT OF LOWER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: The Drugs & Therapeutics Committee Date: July 2018 Implementation
More informationA Nightmare. R Dulgheru, CHU Liege
A Nightmare R Dulgheru, CHU Liege Faculty disclosure Raluca Dulgheru I have no financial relationships to disclose. MB, 57 years old male 18/03/2016 to the ER for altered mental status, First weight name
More information109 Infective Endocarditis
Página 1 de 30 Copyright 2005 McGraw-Hill Kasper, Dennis L., Fauci, Anthony S., Longo, Dan L., Braunwald, Eugene, Hauser, Stephen L., Jameson, J. Larry, Harrison, T. R., Resnick, W. R., Wintrobe, M. M.,
More informationMICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS
When to Order a Urine Culture: Asymptomatic bacteriuria is often treated unnecessarily, and accounts for a substantial burden of unnecessary antimicrobial use. National guidelines recommend against testing
More informationHaemodialysis central venous catheter-related sepsis management guideline Version 3. NAME M. Letheren Chair Clinical Effectiveness Advisory Group
Lancashire Teaching Hospitals NHS Foundation Trust Haemodialysis central venous catheter-related sepsis management guideline Version 3 AUTHOR APPROVED BY DATE AUTH REF. NO NAME REBG/00018/July12 Michael
More informationWhen the heart rules the head: ischaemic stroke and intracerebral haemorrhage complicating infective endocarditis
When the heart rules the head: ischaemic stroke and intracerebral haemorrhage complicating infective endocarditis Estabrak Jiad MBBS 1 *, Sumanjit K Gill MRCP 1,3 *, Maria Krutikov MB ChB 1 *, David Turner
More information, David Stultz, MD.
http://www.dilbert.com Infective Endocarditis David Stultz, MD Cardiology Fellow, PGY 4 December 8, 2004 Handouts available in PDF format at www.drstultz.com Topics to be covered Epidemiology Microbiology
More informationManagement of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy.
Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy. Written by: Dr K Gajee, Consultant Microbiologist Date: June 2017 Approved by: Drugs & Therapeutics Committee
More informationThis is a repository copy of Antibiotic prophylaxis of endocarditis: a NICE mess.
This is a repository copy of Antibiotic prophylaxis of endocarditis: a NICE mess. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/96643/ Version: Accepted Version Article:
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationPRINCIPLES OF ENDOCARDITIS
015 // Endocarditis CONTENTS 140 Principles of Endocarditis 141 Native Valve Endocarditis 143 Complications of Native Valve Endocarditis 145 Right Heart Endocarditis 145 Prosthetic Valve Endocarditis 146
More informationCLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)
CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological
More informationA Predictable Outcome of a Preventable Disease. Sanjay Kamboj, MD; Shaminder Gupta, MD; Glenn P. Kelley, MD; Fred Helmcke, MD; and Fred A.
Clinical Case of the Month A Predictable Outcome of a Preventable Disease Sanjay Kamboj, MD; Shaminder Gupta, MD; Glenn P. Kelley, MD; Fred Helmcke, MD; and Fred A. Lopez, MD Infective endocarditis is
More informationCLINICAL SYNDROMES: COMMUNITY ACQUIRED INFECTIONS
SECTION 2 CLINICAL SYNDROMES: COMMUNITY ACQUIRED INFECTIONS 118-1 118 Adolf W. Karchmer The prototypic lesion of infective endocarditis, the vegetation (Fig. 118-1), is a mass of platelets, fibrin, microcolonies
More informationInfective Endocarditis for Primary Care Physicians
Infective Endocarditis for Primary Care Physicians David N Gilbert, MD Disclosures Consultant to: Merck Pfizer Medicine Company Cempra 1 Introduction There are roughly 30,000 new cases of IE in the US
More informationUrology and Urinary Tract Infections in Adults
Urology and Urinary Tract Infections in Adults Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version
More informationNeutropenic Sepsis Guideline
Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline - definitions Suspected or proven infection in a neutropenic patient is a MEDICAL EMERGENCY and is an indication for immediate assessment and prompt
More informationD DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2
Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following
More information(Max 2 g) = to nearest 250 mg
Appendix 1 (part 1 of 8): Rubric for competency assessment of pharmacists prescribing and managing vancomycin Empiric Dosing Phase Pts Yes No Data Error OP Did the pharmacist document the indication 2
More informationAHA Scientific Statement
AHA Scientific Statement Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart
More informationINFECTIVE ENDOCARDITIS AMONGST INTRAVENOUS DRUG ABUSERS SEEN AT THE UNIVERSITY HOSPITAL, KUALA LUMPUR
Med. J. Malaysia Vol. 42 No. 4 December 1987 INFECTIVE ENDOCARDITIS AMONGST INTRAVENOUS DRUG ABUSERS SEEN AT THE UNIVERSITY HOSPITAL, KUALA LUMPUR R. JAYAMALAR MBBS, MRCP. "N. PARASAKTHI MBBS, MSc. "S.D.
More informationINFECTIVE ENDOCARDITIS IN CHILDREN
INFECTIVE ENDOCARDITIS IN CHILDREN Rohayati Taib RIPAS Hospital, Bundar Seri Begawan, Brunei Darussalam Infective Endocarditis (IE) is a microbial infection of the endocardium. It encompasses both bacterial
More informationresults in stenosis or insufficiency (regurgitation or incompetence), or both.
results in stenosis or insufficiency (regurgitation or incompetence), or both. The outcome of valvular disease depends on : 1-the valve involved 2-the degree of impairment 3-the cause of its development
More informationConsensus Statement on Infective Endocarditis / Abridged Version
CONSENSUS Consensus Statement on Infective Endocarditis / Abridged Version Argentine Society of Cardiology General Directors Secretary (Area of Regulations and Consensuses) Dr. Gustavo Giunta MTSAC 1.
More informationCardiology III 1/22/2019. Disclosures - none. But first. Objectives. Ischemia EKG s. And second
Disclosures - none Cardiology III Matthew K Hysell, MD Spectrum Health Lakeland St Joseph, MI 1 2 Objectives Review specific high-yield EKG patterns Ischemia Ischemia mimics Electrolytes Review Cardiac/CV
More informationGASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT
GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT Name & Title Of Author: Dr Linda Jewes, Consultant Microbiologist Date Amended: December 2016 Approved by Committee/Group: Drugs & Therapeutics
More informationDiagnosis and management of bacterial endocarditis in 2003 Blaithnead Murtagh, MD, O.H. Frazier, MD, and George V. Letsou, MD
Diagnosis and management of bacterial endocarditis in 2003 Blaithnead Murtagh, MD, O.H. Frazier, MD, and George V. Letsou, MD The diagnosis of infective endocarditis has been notoriously difficult. Over
More informationANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS
ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS Version 4.0 Date ratified February 2009 Review date February 2011 Ratified by Authors Consultation Evidence
More informationMULTIVALVULAR INFECTIVE ENDOCARDITIS CLINICAL FEATURES, ECHOCARDIOGRAPHIC DATA AND OUTCOMES
Article Original MULTIVALVULAR INFECTIVE ENDOCARDITIS CLINICAL FEATURES, ECHOCARDIOGRAPHIC DATA AND OUTCOMES L. ABID, B. JERBI, I. TRABELSI, A. ZNAZEN*, S. KRICHÈNE, D. ABID, M. AKROUT, S. MALLEK, F. TRIKI,
More informationProspective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital
Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Final Results Nathan Beahm, BSP, PharmD(student) September 10, 2016 Objectives Review background information
More informationGUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS
GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS Version 3.0 Date ratified May 2008 Review date May 2010 Ratified by NUH Antibiotic Guidelines Committee NUH Drugs and Therapeutics
More information